National Bank of Canada’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.6K Sell
3,052
-50
-2% -$1.46K ﹤0.01% 1842
2025
Q4
$89.9K Sell
3,102
-476
-13% -$14.3K ﹤0.01% 1802
2025
Q3
$99.4K Buy
3,578
+95
+3% +$2.4K ﹤0.01% 1756
2025
Q2
$84.8K Buy
3,483
+459
+15% +$10.1K ﹤0.01% 1830
2025
Q1
$62.8K Hold
3,024
﹤0.01% 1817
2024
Q4
$71.2K Sell
3,024
-1,131
-27% -$27.8K ﹤0.01% 1840
2024
Q3
$106K Buy
4,155
+920
+28% +$23.4K ﹤0.01% 1520
2024
Q2
$75.9K Buy
3,235
+159
+5% +$4.01K ﹤0.01% 1564
2024
Q1
$76.6K Buy
3,076
+146
+5% +$4.39K ﹤0.01% 1623
2023
Q4
$95.8K Sell
2,930
-395
-12% -$10.7K ﹤0.01% 1583
2023
Q3
$89.4K Buy
3,325
+400
+14% +$13.1K ﹤0.01% 1643
2023
Q2
$99.7K Sell
2,925
-109
-4% -$3.43K ﹤0.01% 1592
2023
Q1
$91.3K Sell
3,034
-86,280
-97% -$2.67M ﹤0.01% 1552
2022
Q4
$2.52M Buy
89,314
+16,956
+23% +$538K 0.01% 813
2022
Q3
$2.37M Buy
72,358
+41,137
+132% +$1.51M 0.01% 746
2022
Q2
$983K Sell
31,221
-277,155
-90% -$9.69M ﹤0.01% 1021
2022
Q1
$14.2M Sell
308,376
-154,672
-33% -$7.37M 0.04% 376
2021
Q4
$28.4M Buy
+463,048
New +$32M 0.1% 182

Other funds holding ARKG

National Bank of Canada's ARKG Position: Q1 2026 in Review

National Bank of Canada reduced its ARK Genomic Revolution ETF (ARKG) stake by 1.6% in Q1 2026, selling an estimated $1.46K and leaving 3,052 shares worth $80.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1842.

National Bank of Canada first reported a position in ARKG in Q4 2021 and has held it in 18 quarters since. The position peaked at $28.4M in Q4 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • National Bank of Canada held 3,052 shares of ARK Genomic Revolution ETF worth $80.6K as of Q1 2026.
  • National Bank of Canada sold 50 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $1.46K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1842 holding.
  • National Bank of Canada first reported a position in ARK Genomic Revolution ETF in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's ARK Genomic Revolution ETF position peaked at $28.4M in Q4 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.